Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Dermatology Drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases.
Dermatology Drug market report explains the definition, types, applications, major countries, and major players of the Dermatology Drug market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
GlaxoSmithKline
Johnson & Johnson
Merz Pharma
Bayer
Pfizer
Valeant
Galderma
Bristol-Myers Squibb
LEO Pharma
AbbVie
Novartis
By Type:
External Use
Oral
Injection
By End-User:
Psoriasis
Skin Infections
Acne
Dermatitis
Other
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Dermatology Drug Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Dermatology Drug Outlook to 2028- Original Forecasts
-
2.2 Dermatology Drug Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Dermatology Drug Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Dermatology Drug Market- Recent Developments
-
6.1 Dermatology Drug Market News and Developments
-
6.2 Dermatology Drug Market Deals Landscape
7 Dermatology Drug Raw Materials and Cost Structure Analysis
-
7.1 Dermatology Drug Key Raw Materials
-
7.2 Dermatology Drug Price Trend of Key Raw Materials
-
7.3 Dermatology Drug Key Suppliers of Raw Materials
-
7.4 Dermatology Drug Market Concentration Rate of Raw Materials
-
7.5 Dermatology Drug Cost Structure Analysis
-
7.5.1 Dermatology Drug Raw Materials Analysis
-
7.5.2 Dermatology Drug Labor Cost Analysis
-
7.5.3 Dermatology Drug Manufacturing Expenses Analysis
8 Global Dermatology Drug Import and Export Analysis (Top 10 Countries)
-
8.1 Global Dermatology Drug Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Dermatology Drug Export by Region (Top 10 Countries) (2017-2028)
9 Global Dermatology Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Dermatology Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global External Use Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Oral Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Injection Consumption and Growth Rate (2017-2022)
-
9.2 Global Dermatology Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Psoriasis Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Skin Infections Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Acne Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Dermatitis Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Other Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Dermatology Drug Market Analysis and Outlook till 2022
-
10.1 Global Dermatology Drug Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Dermatology Drug Consumption (2017-2022)
-
10.2.2 Canada Dermatology Drug Consumption (2017-2022)
-
10.2.3 Mexico Dermatology Drug Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Dermatology Drug Consumption (2017-2022)
-
10.3.2 UK Dermatology Drug Consumption (2017-2022)
-
10.3.3 Spain Dermatology Drug Consumption (2017-2022)
-
10.3.4 Belgium Dermatology Drug Consumption (2017-2022)
-
10.3.5 France Dermatology Drug Consumption (2017-2022)
-
10.3.6 Italy Dermatology Drug Consumption (2017-2022)
-
10.3.7 Denmark Dermatology Drug Consumption (2017-2022)
-
10.3.8 Finland Dermatology Drug Consumption (2017-2022)
-
10.3.9 Norway Dermatology Drug Consumption (2017-2022)
-
10.3.10 Sweden Dermatology Drug Consumption (2017-2022)
-
10.3.11 Poland Dermatology Drug Consumption (2017-2022)
-
10.3.12 Russia Dermatology Drug Consumption (2017-2022)
-
10.3.13 Turkey Dermatology Drug Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Dermatology Drug Consumption (2017-2022)
-
10.4.2 Japan Dermatology Drug Consumption (2017-2022)
-
10.4.3 India Dermatology Drug Consumption (2017-2022)
-
10.4.4 South Korea Dermatology Drug Consumption (2017-2022)
-
10.4.5 Pakistan Dermatology Drug Consumption (2017-2022)
-
10.4.6 Bangladesh Dermatology Drug Consumption (2017-2022)
-
10.4.7 Indonesia Dermatology Drug Consumption (2017-2022)
-
10.4.8 Thailand Dermatology Drug Consumption (2017-2022)
-
10.4.9 Singapore Dermatology Drug Consumption (2017-2022)
-
10.4.10 Malaysia Dermatology Drug Consumption (2017-2022)
-
10.4.11 Philippines Dermatology Drug Consumption (2017-2022)
-
10.4.12 Vietnam Dermatology Drug Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Dermatology Drug Consumption (2017-2022)
-
10.5.2 Colombia Dermatology Drug Consumption (2017-2022)
-
10.5.3 Chile Dermatology Drug Consumption (2017-2022)
-
10.5.4 Argentina Dermatology Drug Consumption (2017-2022)
-
10.5.5 Venezuela Dermatology Drug Consumption (2017-2022)
-
10.5.6 Peru Dermatology Drug Consumption (2017-2022)
-
10.5.7 Puerto Rico Dermatology Drug Consumption (2017-2022)
-
10.5.8 Ecuador Dermatology Drug Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Dermatology Drug Consumption (2017-2022)
-
10.6.2 Kuwait Dermatology Drug Consumption (2017-2022)
-
10.6.3 Oman Dermatology Drug Consumption (2017-2022)
-
10.6.4 Qatar Dermatology Drug Consumption (2017-2022)
-
10.6.5 Saudi Arabia Dermatology Drug Consumption (2017-2022)
-
10.6.6 United Arab Emirates Dermatology Drug Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Dermatology Drug Consumption (2017-2022)
-
10.7.2 South Africa Dermatology Drug Consumption (2017-2022)
-
10.7.3 Egypt Dermatology Drug Consumption (2017-2022)
-
10.7.4 Algeria Dermatology Drug Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Dermatology Drug Consumption (2017-2022)
-
10.8.2 New Zealand Dermatology Drug Consumption (2017-2022)
11 Global Dermatology Drug Competitive Analysis
-
11.1 GlaxoSmithKline
-
11.1.1 GlaxoSmithKline Company Details
-
11.1.2 GlaxoSmithKline Dermatology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 GlaxoSmithKline Dermatology Drug Main Business and Markets Served
-
11.1.4 GlaxoSmithKline Dermatology Drug Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Johnson & Johnson
-
11.2.1 Johnson & Johnson Company Details
-
11.2.2 Johnson & Johnson Dermatology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Johnson & Johnson Dermatology Drug Main Business and Markets Served
-
11.2.4 Johnson & Johnson Dermatology Drug Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Merz Pharma
-
11.3.1 Merz Pharma Company Details
-
11.3.2 Merz Pharma Dermatology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Merz Pharma Dermatology Drug Main Business and Markets Served
-
11.3.4 Merz Pharma Dermatology Drug Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Bayer
-
11.4.1 Bayer Company Details
-
11.4.2 Bayer Dermatology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Bayer Dermatology Drug Main Business and Markets Served
-
11.4.4 Bayer Dermatology Drug Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Pfizer
-
11.5.1 Pfizer Company Details
-
11.5.2 Pfizer Dermatology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Pfizer Dermatology Drug Main Business and Markets Served
-
11.5.4 Pfizer Dermatology Drug Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Valeant
-
11.6.1 Valeant Company Details
-
11.6.2 Valeant Dermatology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Valeant Dermatology Drug Main Business and Markets Served
-
11.6.4 Valeant Dermatology Drug Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Galderma
-
11.7.1 Galderma Company Details
-
11.7.2 Galderma Dermatology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Galderma Dermatology Drug Main Business and Markets Served
-
11.7.4 Galderma Dermatology Drug Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Bristol-Myers Squibb
-
11.8.1 Bristol-Myers Squibb Company Details
-
11.8.2 Bristol-Myers Squibb Dermatology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Bristol-Myers Squibb Dermatology Drug Main Business and Markets Served
-
11.8.4 Bristol-Myers Squibb Dermatology Drug Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 LEO Pharma
-
11.9.1 LEO Pharma Company Details
-
11.9.2 LEO Pharma Dermatology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 LEO Pharma Dermatology Drug Main Business and Markets Served
-
11.9.4 LEO Pharma Dermatology Drug Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 AbbVie
-
11.10.1 AbbVie Company Details
-
11.10.2 AbbVie Dermatology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 AbbVie Dermatology Drug Main Business and Markets Served
-
11.10.4 AbbVie Dermatology Drug Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Novartis
-
11.11.1 Novartis Company Details
-
11.11.2 Novartis Dermatology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Novartis Dermatology Drug Main Business and Markets Served
-
11.11.4 Novartis Dermatology Drug Product Portfolio
-
11.11.5 Recent Research and Development Strategies
12 Global Dermatology Drug Market Outlook by Types and Applications to 2028
-
12.1 Global Dermatology Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global External Use Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Dermatology Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Psoriasis Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Skin Infections Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Acne Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Dermatitis Consumption Forecast and Growth Rate (2022-2028)
-
12.2.5 Global Other Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Dermatology Drug Market Analysis and Outlook to 2028
-
13.1 Global Dermatology Drug Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Dermatology Drug Consumption Forecast (2022-2028)
-
13.2.2 Canada Dermatology Drug Consumption Forecast (2022-2028)
-
13.2.3 Mexico Dermatology Drug Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Dermatology Drug Consumption Forecast (2022-2028)
-
13.3.2 UK Dermatology Drug Consumption Forecast (2022-2028)
-
13.3.3 Spain Dermatology Drug Consumption Forecast (2022-2028)
-
13.3.4 Belgium Dermatology Drug Consumption Forecast (2022-2028)
-
13.3.5 France Dermatology Drug Consumption Forecast (2022-2028)
-
13.3.6 Italy Dermatology Drug Consumption Forecast (2022-2028)
-
13.3.7 Denmark Dermatology Drug Consumption Forecast (2022-2028)
-
13.3.8 Finland Dermatology Drug Consumption Forecast (2022-2028)
-
13.3.9 Norway Dermatology Drug Consumption Forecast (2022-2028)
-
13.3.10 Sweden Dermatology Drug Consumption Forecast (2022-2028)
-
13.3.11 Poland Dermatology Drug Consumption Forecast (2022-2028)
-
13.3.12 Russia Dermatology Drug Consumption Forecast (2022-2028)
-
13.3.13 Turkey Dermatology Drug Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Dermatology Drug Consumption Forecast (2022-2028)
-
13.4.2 Japan Dermatology Drug Consumption Forecast (2022-2028)
-
13.4.3 India Dermatology Drug Consumption Forecast (2022-2028)
-
13.4.4 South Korea Dermatology Drug Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Dermatology Drug Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Dermatology Drug Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Dermatology Drug Consumption Forecast (2022-2028)
-
13.4.8 Thailand Dermatology Drug Consumption Forecast (2022-2028)
-
13.4.9 Singapore Dermatology Drug Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Dermatology Drug Consumption Forecast (2022-2028)
-
13.4.11 Philippines Dermatology Drug Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Dermatology Drug Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Dermatology Drug Consumption Forecast (2022-2028)
-
13.5.2 Colombia Dermatology Drug Consumption Forecast (2022-2028)
-
13.5.3 Chile Dermatology Drug Consumption Forecast (2022-2028)
-
13.5.4 Argentina Dermatology Drug Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Dermatology Drug Consumption Forecast (2022-2028)
-
13.5.6 Peru Dermatology Drug Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Dermatology Drug Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Dermatology Drug Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Dermatology Drug Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Dermatology Drug Consumption Forecast (2022-2028)
-
13.6.3 Oman Dermatology Drug Consumption Forecast (2022-2028)
-
13.6.4 Qatar Dermatology Drug Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Dermatology Drug Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Dermatology Drug Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Dermatology Drug Consumption Forecast (2022-2028)
-
13.7.2 South Africa Dermatology Drug Consumption Forecast (2022-2028)
-
13.7.3 Egypt Dermatology Drug Consumption Forecast (2022-2028)
-
13.7.4 Algeria Dermatology Drug Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Dermatology Drug Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Dermatology Drug Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Dermatology Drug
-
Figure of Dermatology Drug Picture
-
Table Global Dermatology Drug Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Dermatology Drug Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global External Use Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Consumption and Growth Rate (2017-2022)
-
Figure Global Injection Consumption and Growth Rate (2017-2022)
-
Figure Global Psoriasis Consumption and Growth Rate (2017-2022)
-
Figure Global Skin Infections Consumption and Growth Rate (2017-2022)
-
Figure Global Acne Consumption and Growth Rate (2017-2022)
-
Figure Global Dermatitis Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Dermatology Drug Consumption by Country (2017-2022)
-
Table North America Dermatology Drug Consumption by Country (2017-2022)
-
Figure United States Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure Canada Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure Mexico Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Dermatology Drug Consumption by Country (2017-2022)
-
Figure Germany Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure UK Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure Spain Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure Belgium Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure France Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure Italy Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure Denmark Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure Finland Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure Norway Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure Sweden Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure Poland Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure Russia Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure Turkey Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Table APAC Dermatology Drug Consumption by Country (2017-2022)
-
Figure China Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure India Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure Thailand Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure Singapore Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure Philippines Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Table South America Dermatology Drug Consumption by Country (2017-2022)
-
Figure Brazil Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure Colombia Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure Chile Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure Argentina Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure Peru Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Table GCC Dermatology Drug Consumption by Country (2017-2022)
-
Figure Bahrain Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure Oman Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure Qatar Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Table Africa Dermatology Drug Consumption by Country (2017-2022)
-
Figure Nigeria Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure South Africa Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure Egypt Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure Algeria Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Table Oceania Dermatology Drug Consumption by Country (2017-2022)
-
Figure Australia Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Dermatology Drug Consumption and Growth Rate (2017-2022)
-
Table GlaxoSmithKline Company Details
-
Table GlaxoSmithKline Dermatology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Dermatology Drug Main Business and Markets Served
-
Table GlaxoSmithKline Dermatology Drug Product Portfolio
-
Table Johnson & Johnson Company Details
-
Table Johnson & Johnson Dermatology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Dermatology Drug Main Business and Markets Served
-
Table Johnson & Johnson Dermatology Drug Product Portfolio
-
Table Merz Pharma Company Details
-
Table Merz Pharma Dermatology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merz Pharma Dermatology Drug Main Business and Markets Served
-
Table Merz Pharma Dermatology Drug Product Portfolio
-
Table Bayer Company Details
-
Table Bayer Dermatology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Dermatology Drug Main Business and Markets Served
-
Table Bayer Dermatology Drug Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Dermatology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Dermatology Drug Main Business and Markets Served
-
Table Pfizer Dermatology Drug Product Portfolio
-
Table Valeant Company Details
-
Table Valeant Dermatology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Valeant Dermatology Drug Main Business and Markets Served
-
Table Valeant Dermatology Drug Product Portfolio
-
Table Galderma Company Details
-
Table Galderma Dermatology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Galderma Dermatology Drug Main Business and Markets Served
-
Table Galderma Dermatology Drug Product Portfolio
-
Table Bristol-Myers Squibb Company Details
-
Table Bristol-Myers Squibb Dermatology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Dermatology Drug Main Business and Markets Served
-
Table Bristol-Myers Squibb Dermatology Drug Product Portfolio
-
Table LEO Pharma Company Details
-
Table LEO Pharma Dermatology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table LEO Pharma Dermatology Drug Main Business and Markets Served
-
Table LEO Pharma Dermatology Drug Product Portfolio
-
Table AbbVie Company Details
-
Table AbbVie Dermatology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Dermatology Drug Main Business and Markets Served
-
Table AbbVie Dermatology Drug Product Portfolio
-
Table Novartis Company Details
-
Table Novartis Dermatology Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Dermatology Drug Main Business and Markets Served
-
Table Novartis Dermatology Drug Product Portfolio
-
Figure Global External Use Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Psoriasis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Skin Infections Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Acne Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dermatitis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dermatology Drug Consumption Forecast by Country (2022-2028)
-
Table North America Dermatology Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Dermatology Drug Consumption Forecast by Country (2022-2028)
-
Figure Germany Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Dermatology Drug Consumption Forecast by Country (2022-2028)
-
Figure China Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Dermatology Drug Consumption Forecast by Country (2022-2028)
-
Figure Brazil Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Dermatology Drug Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Dermatology Drug Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Dermatology Drug Consumption Forecast by Country (2022-2028)
-
Figure Australia Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Dermatology Drug Consumption Forecast and Growth Rate (2022-2028)
-
